|
Product Details:
|
| Color: | White | CAS: | 122320-73-4 |
|---|---|---|---|
| Usage: | Antidiabetic Raw Powders | Alias: | Avandia |
| Product Categories: | Active Pharmaceutical Ingredients | Vapor Pressure: | 1.14E-13mmHg At 25°C |
| High Light: | Pharma Raw Oral Hypoglycemic Agents,Oral Hypoglycemic Agents 122320-73-4,122320-73-4 Medical Rosiglitazone Powder |
||
Pharma Raw Rosiglitazone Medical Oral Hypoglycemic Agents Raw Material 122320-73-4
| Product name | Rosiglitazone Maleate |
| CAS | 122320-73-4 |
| Alias | Avandia |
| MF | C22H23N3O7S |
| MW | 473.5 |
| Product Categories | Active Pharmaceutical Ingredients |
| Melting point | 235-240°C |
| Storage temp. | -20°C Freezer |
| Appearance | White Powders |
| Usage | Rosiglitazone is an insulin sensitizer; binds to peroxisome proliferator activated receptor gamma (PPAR- γ). |
| M.S. |  |
Description
Rosiglitazone and pioglitazone is currently the clinical treatment of diabetes commonly used thiazolidinedione hypoglycemic agents, this product is insulin sensitizer, by increasing the skeletal muscle, liver, adipose tissue sensitivity to insulin, improve cell pairs Glucose utilization and play a lower blood sugar effect, can significantly reduce the fasting blood glucose and insulin, C peptide levels, postprandial blood glucose and insulin also have a lower effect.
But requires patients to have a certain ability to secrete insulin. Clinical application for diet control and exercise is still not satisfied with type 2 diabetes patients, but also with biguanide or sulfonylurea combination therapy alone when the poor control of blood sugar. Single use, the initial dose of oral daily 4mg, 12 weeks after the need to increase to 8mg daily. In fasting or eating clothes After the elderly patients may have mild to moderate edema and anemia, edema patients with caution.
| Properties | |
| Appearance: | White to off-white crystalline powder |
| Density: | 1.315g/cm3 |
| Melting Point: | 153-155ºC |
| Boiling Point: | 585ºC at 760mmHg |
| Flash Point: | 307.6ºC |
| Vapor Pressure: | 1.14E-13mmHg at 25°C |
Indications and Usage
| 1. Monotherapy and Combination Therapy | Rosiglitazone Tartrate Dispersible Tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. |
| 2. Important Limitations of Use |
Due to its mechanism of action, Rosiglitazone Tartrate Dispersible Tablets is active only in the presence of endogenous insulin. Therefore, Rosiglitazone Tartrate Dispersible Tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
The use of Rosiglitazone Tartrate Dispersible Tablets with nitrates is not recommended. |
Shipping & Delivery
1. Packages are generally dispatched within approximately 2 days after receipt of payment.
2. After the each shipping we will provide you with:
1) a link & tracking number to track your package online.
2) the few pictures with your order & details.
3. About the Custom clearance,we packed in disguise ways.In our experience,the appropriate and safe delivery,there won't be problems.
4. We confirm 99% clearance,100% resending.
5. Is it the best & safest shipping for all our repeat customers!
Contact Person: 张国庆
Tel: +861314804998
